Mirum Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	324.91	296.68	222.5	286.33	28	31.34
Short-Term Investments	61.35	86.64	57.81	-	123.72	125.2
Cash & Short-Term Investments	386.26	383.33	280.32	286.33	151.72	156.54
Cash Growth	39.11%	36.75%	-2.10%	88.72%	-3.08%	-32.47%
Accounts Receivable	133.11	123.33	78.29	67.97	23.99	3.27
Inventory	25.52	24.89	22.4	22.31	5.57	1.51
Other Current Assets	24.55	18.14	11.78	10.94	8.95	5.27
Total Current Assets	569.44	549.68	392.79	387.54	190.23	166.59
Net Property, Plant & Equipment	15.06	10.6	9.81	1.99	60.39	2.55
Other Intangible Assets	254.15	260.92	249.82	252.93	1.38	18.74
Long-Term Investments	34.35	8.11	12.53	-	-	4.98
Other Long-Term Assets	17.91	13.5	5.81	4.17	0.91	101.79
Total Assets	890.92	842.81	670.75	646.62	352.91	294.65
Accounts Payable	59.4	9.61	14.62	7.42	8.69	9.17
Accrued Expenses	187.63	196.19	111.93	78.54	54.02	30.72
Current Portion of Leases	-	-	-	1.1	0.93	0.71
Other Current Liabilities	25.8	-	-	-	1.09	2
Total Current Liabilities	272.82	205.8	126.55	87.06	64.73	42.6
Long-Term Debt	310.25	309.8	308.08	306.42	-	-
Long-Term Leases	11.18	7.52	7.97	0.62	1.26	1.9
Other Long-Term Liabilities	54.17	5.01	2.51	3.85	144.88	129.94
Total Long-Term Liabilities	375.6	322.32	318.56	310.89	146.14	131.84
Total Liabilities	648.42	528.12	445.11	397.95	210.87	174.44
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	1,700	981.88	870.19	803.26	535.07	377.4
Accumulated Other Comprehensive Income	-0.03	0.35	-0.37	1.64	-0.22	-0.04
Retained Earnings	-1,458	-667.54	-644.18	-556.24	-392.82	-257.16
Shareholders' Equity	242.49	314.69	225.64	248.67	142.04	120.21
Total Liabilities & Equity	890.92	842.81	670.75	646.62	352.91	294.65
Total Debt	321.43	317.31	316.05	308.14	2.19	2.61
Net Cash (Debt)	64.83	66.01	-35.74	-21.82	149.53	153.93
Net Cash Growth	-1.79%	-	-	-	-2.86%	-32.65%
Net Cash Per Share	1.20	1.31	-0.75	-0.53	4.40	5.08
Book Value	242.49	314.69	225.64	248.67	142.04	120.21
Book Value Per Share	4.47	6.27	4.75	6.08	4.18	3.96
Tangible Book Value	-11.66	53.77	-24.18	-4.26	140.66	101.47
Tangible Book Value Per Share	-0.21	1.07	-0.51	-0.10	4.14	3.35

SEC Filings: 10-K · 10-Q